Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20+
SponsorTaipei Veterans General Hospital, Taiwan

About this trial

Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.

Eligibility criteria

Qualifiers

Patients who have instrumented spine fusion surgery due to failed conservative treatment (bed rest, medication, rehabilitation programs) for 3 to 6 months

Patients who are willing to sign the surgical permit after the surgeon explains all surgical procedures along with the surgical risks

Patients who fully understand the surgical procedures as well as the surgical risks and are willing to sign the surgical permit and the inform consent

Patients who agree one more blood withdrawal after operation

Disqualifiers

Patients who agree to accept the spine surgery but do not agree to sign the inform consent

Patients who have allergic reaction to vancomycin

Trial design

Treatments tested in this trial

  • with U-VANCO (vancomycin hydrochloride)
  • without U-VANCO (vancomycin hydrochloride)

Treatment groups

400 Participants
are divided into 2 treatment groups